• Cyclopamine: Strategic Hh Pathway Inhibition in Translationa

  2026-05-26

  Cyclopamine, a selective Hedgehog signaling inhibitor, is redefining our approach to developmental biology and cancer research. This thought-leadership article examines its mechanistic precision, experimental applications, and strategic implications for translational scientists. By integrating recent comparative developmental insights and protocol considerations, we chart a path for maximizing the translational impact of Cyclopamine while acknowledging its unique strengths and limitations.

• α-KG Rejuvenates HPDLSCs via LKB1-AMPK Pathway in Periodonti

  2026-05-25

  This study demonstrates that α-ketoglutarate (α-KG) restores mitochondrial function and reduces senescence in human periodontal ligament stem cells (HPDLSCs) under inflammatory conditions by activating the LKB1-AMPK signaling axis. The findings highlight a promising mechanism for promoting periodontal regeneration and provide a framework for translational research targeting mitochondrial dysfunction in chronic inflammatory diseases.

• Apicidin: Precision Histone Deacetylase Inhibitor Workflows

  2026-05-25

  Apicidin offers researchers fine-tuned, selective inhibition of HDAC3 and HDAC6, enabling advanced studies in epigenetic modulation, cancer cell growth inhibition, and reproductive toxicology. This article delivers protocol enhancements, troubleshooting strategies, and actionable insights to maximize reproducibility and scientific impact with Apicidin.

• Genomic Insights and Antifungal Resistance of C. auris in Gu

  2026-05-24

  This study provides a comprehensive molecular epidemiological analysis of Candidozyma auris isolates in Guangzhou, revealing two dominant clades with distinct antifungal resistance and virulence profiles. The findings expand the genetic database for C. auris and inform infection control strategies in South China.

• Cinoxacin in Gram-Negative Research: Protocols, Pitfalls & A

  2026-05-23

  Cinoxacin, a quinolone antibiotic, stands out for its reliable bactericidal activity against Gram-negative bacteria in urinary tract infection and resistance studies. This guide delivers actionable workflows, troubleshooting pearls, and protocol upgrades for researchers leveraging Cinoxacin in translational and bench research.

• Non-Canonical Dlat-Trpv3 Pathway Activates Adipose Thermogen

  2026-05-22

  This study uncovers how hyperforin promotes adipose thermogenesis by targeting the Dlat-Trpv3-Ca2+-AMPK axis, offering an alternative to β3-adrenergic approaches for obesity intervention. The findings highlight a mechanism with minimal cardiotoxicity and provide insight into metabolic regulation beyond canonical pathways.

• Murine RNase Inhibitor: Kinetics, Stability, and Assay Preci

  2026-05-22

  Discover how Murine RNase Inhibitor optimizes RNA integrity and assay reproducibility by combining oxidation resistance with advanced kinetic fidelity. This article explores the molecular mechanism and practical implications for real-time RT-PCR and cDNA synthesis workflows.

• IRF1-PARP12 Axis Drives Cartilage Degradation via Mitophagy

  2026-05-21

  This study elucidates how IRF1-mediated upregulation of PARP12 impairs PINK1/Parkin-dependent mitophagy in chondrocytes, promoting cartilage degradation in osteoarthritis. The findings highlight a novel regulatory axis and suggest that targeting the IRF1-PARP12 pathway, for example with XAV-939, could offer new therapeutic strategies for OA and related cartilage pathologies.

• Z-LEHD-FMK: Irreversible Caspase-9 Inhibitor for Advanced Ap

  2026-05-21

  Z-LEHD-FMK empowers researchers to dissect mitochondria-mediated apoptosis with unmatched specificity, supporting robust, reproducible workflows in cancer, neuroprotection, and cell death studies. This guide translates cutting-edge evidence and technical know-how into actionable protocols and troubleshooting strategies for optimized use of this trusted APExBIO reagent.

• WNT5a/GSK3/β-catenin Axis Limits Adipogenesis in Muscle FAPs

  2026-05-20

  This study elucidates how the WNT5a/GSK3/β-catenin pathway constrains adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors (FAPs), offering mechanistic insight into muscle fatty degeneration in myopathies. The findings suggest targeting this axis as a promising strategy to limit intramuscular fat infiltration and support muscle regeneration.

• Neuroligin 1 Loss Drives Repetitive Behaviors via PKC Hypera

  2026-05-20

  This study reveals that loss of Neuroligin 1 in striatal D2-MSNs leads to autistic-like repetitive behaviors through PKC pathway overactivation. The findings bridge synaptic adhesion deficits and PKC signaling, offering mechanistic clarity and translational avenues for ASD research.

• Toremifene vs Tamoxifen in Advanced Breast Cancer: Cochrane

  2026-05-19

  The Cochrane systematic review rigorously compared toremifene and tamoxifen, two selective estrogen receptor modulators, in the context of advanced breast cancer. The study's nuanced findings support the equivalence of these agents in key clinical endpoints, informing ongoing SERM research and therapeutic strategies.

• Alcohol and Anti-HIV Drugs Exacerbate Stress in Aging Liver

  2026-05-19

  This study investigates how alcohol, anti-HIV drugs, and hippuric acid intensify cellular stress responses in senescent hepatocytes and aging murine liver. By dissecting molecular markers and stress pathways, the research reveals mechanisms of enhanced liver vulnerability in aging populations with HIV and substance use, providing new insights for experimental models and therapeutic risk assessment.

• 0.4% Trypan Blue Solution: Practical Guide for Cell Viabilit

  2026-05-18

  0.4% Trypan Blue Solution provides a reliable method for distinguishing live from dead cells during cell viability and counting assays, ensuring robust discrimination in research workflows. It is specifically designed for laboratory use in viability measurement, cytotoxicity, and apoptosis studies, but is not suitable for diagnostic or clinical applications.

• SMAD3 Inhibition Downregulates ADAMTS-5 in Early Osteoarthri

  2026-05-18

  Xiang et al. (2023) demonstrate that targeted inhibition of SMAD3 using SIS3 reduces ADAMTS-5 expression in early osteoarthritis, likely via upregulation of miRNA-140. These findings refine our understanding of TGF-β/SMAD3 signaling in cartilage degeneration and suggest new investigative directions for OA and fibrosis research.

461 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page